Ceftizoxime: Antimicrobial Activity, Susceptibility, Administration and Dosage, Clinical Uses etc.
These cephalosporins are referred to as extended-spectrum or third-generation cephalosporins because they were developed after the first- and second-generation drugs.
Mar 24,2022 APIToxicity of Enoxacin
Enoxacin is an early-generation fluoroquinolone with the chemical formula (l-ethyl-6-fluoro-I,4-dihydro-4-oxo-7 piperazinyl)-I,8- naphthyridine-3-carboxylic acid. Overall, the in vitro activity of eno
Mar 24,2022 APIUse of 9-Fluorenone
9-Fluorenone is an important chemical substance whose molecular formula is C13H8O
Mar 24,2022 APIThe preparation of pinacol
Pinacol , tetramethylethylene glycol, is also known as 2,3-dimethyl-2,3-dihydroxybutane.
Mar 24,2022 APIPharmacological action of trimethoprim
Trimethoprim, abbreviated as TMP, is an organic compound with chemical formula C14H18N4O3, white or to pale yellow crystalline powder
Mar 24,2022 APIApplications of potassium peroxymonosulfate
Potassium peroxymonosulfate disinfectants (PMS) is an improvement on chlorine-based disinfectants and cleaning agents.
Mar 24,2022 APISide-effects of Sitafloxacin
Sitafloxacin (as sitafloxacin hydrate) is available as 50-mg tablets, under the name Gracevit, and as a 10% fine granular preparation. Sitafloxacin inhibits bacterial topoisomerase II (DNA gyrase) and
Mar 23,2022 APIMechanism and Uses of Gemifloxacin
Gemifloxacin, although technically a 6-fluoronaphthyridone, is usually considered among the closely related fluoroquinolone class of antimicrobial agents. Originally designated LB20304, gemifloxacin w
Mar 23,2022 APICeftriaxone: Antimicrobial Activity, Susceptibility, Administration and Dosage, Pharmacokinetics etc.
Ceftriaxone (Ro 13-9904) is a 2-aminothiazolyl methoxyimino thirdgeneration cephalosporin derivative (Figure 27.1). Ceftriaxone offers good activity against many wild-type Gram-negative organisms wit
Mar 23,2022 APICefotaxime: Clinical Uses and Toxicity
Similar to ceftriaxone, cefotaxime is effective in a wide variety of clinical indications.
Mar 23,2022 API












